Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
Drug firms 'block cheap medicine'
A “mass casualty incident” was declared at a Pennsylvania event on July 2 due to heat...
